Use restrictions for Janus kinase inhibitors

被引：0
|
作者：
Derrien, Elisa
机构：
来源：
ACTUALITES PHARMACEUTIQUES | 2023年 / 62卷 / 627期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Thromboembolism and Janus Kinase Inhibitors
    Ibrahim, Fowzia
    Scott, David L.
    DRUG SAFETY, 2020, 43 (09) : 831 - 833
  • [22] Janus-Kinase-HemmerJanus kinase inhibitors
    E. Ostermeier
    P. Roll
    H.-P. Tony
    Zeitschrift für Rheumatologie, 2012, 71 : 473 - 478
  • [23] Commentary: Janus kinase inhibitors and their use in autoimmune ocular inflammatory disorders
    Moreker, Mayur R.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (09) : 1939 - 1940
  • [24] Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future
    Updyke, Katelyn Mariko
    DERMATOLOGIC THERAPY, 2018, 31 (01)
  • [25] Janus kinase inhibitors State of the art in clinical use and future perspectives
    Alten, R.
    Mischkewitz, M.
    Stefanski, A. -L.
    Doerner, T.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 241 - 254
  • [26] The Development and Use of Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms
    Hobbs, Gabriela S.
    Rozelle, Sarah
    Mullally, Ann
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (04) : 613 - +
  • [27] Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus
    Huo, Rongxiu
    Huang, Xinxiang
    Yang, Yang
    Lin, Jinying
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1471 - 1478
  • [28] Janus kinase inhibitors: efficacy and safety
    Cohen, Stanley
    Reddy, Virginia
    CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (06) : 429 - 434
  • [29] What are Janus kinase (JAK) inhibitors?
    Castelo-Soccio, Leslie
    Siegel, Liza
    PEDIATRIC DERMATOLOGY, 2025, 42 (01) : E1 - E2
  • [30] Janus kinase inhibitors for rheumatoid arthritis
    Yamaoka, Kunihiro
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2016, 32 : 29 - 33
12345